Home> Products> cardiovascular protection drugs india

{ "products": [ { "_id": "681b27d88c5c5327480972c8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "CARDULES ISMN 20", "description": "CARDULES ISMN 20 is a trusted cardiovascular medication formulated with Isosorbide Mononitrate 20 mg, primarily used to prevent and manage angina pectoris (chest pain) due to coronary artery disease. This medicine belongs to the class of drugs known as nitrates, which work by relaxing and widening the blood vessels, improving blood flow to the heart, and reducing its workload. CARDULES ISMN 20 plays a critical role in preventing episodes of angina, enhancing patient quality of life, and lowering the risk of heart-related complications when taken as prescribed.\n\nKey Ingredient\nIsosorbide Mononitrate (20 mg): A long-acting nitrate compound that acts as a vasodilator to reduce myocardial oxygen demand and improve oxygen supply to the heart.\n\nKey Benefits\nPrevents Angina Attacks: Helps in reducing the frequency and severity of chest pain episodes.\n\nImproves Heart Efficiency: Enhances blood flow and reduces the workload on the heart, making it easier for the heart to pump effectively.\n\nReduces Risk of Hospitalization: Long-term use helps reduce emergency visits and admissions due to angina.\n\nPromotes Better Exercise Tolerance: Allows patients with stable angina to engage in physical activity with reduced risk of chest pain.\n\nLong-Acting Relief: Designed for prolonged action, providing extended protection throughout the day when taken regularly.\n\nHow Does It Work?\nIsosorbide Mononitrate, the active ingredient in CARDULES ISMN 20, is a vasodilator that works by releasing nitric oxide, a natural compound in the body that relaxes smooth muscles of the blood vessels. This relaxation causes the veins and arteries to widen, which reduces the pressure on the heart and lowers oxygen demand. It also improves blood flow to the heart muscle, thereby preventing angina attacks. Unlike short-acting nitrates, Isosorbide Mononitrate has a prolonged action, making it suitable for maintenance therapy in chronic angina.\n\nDirections for Use\nTake CARDULES ISMN 20 exactly as prescribed by your physician.\n\nUsually taken once or twice daily, preferably in the morning and afternoon.\n\nSwallow the tablet whole with water; do not crush or chew.\n\nTake the medication on an empty stomach or after a light meal.\n\nMaintain consistent timing every day to achieve the best therapeutic effect.\n\nDo not stop suddenly without consulting your healthcare provider, as it may lead to worsening angina.\n\nImportant: Follow the nitrate-free interval as directed by your doctor to avoid nitrate tolerance (reduced effectiveness over time).\n\nSide Effects\nLike all medications, CARDULES ISMN 20 may cause side effects in some individuals. These are usually mild and temporary but should be monitored.\n\nCommon Side Effects:\n\nHeadache\n\nDizziness or lightheadedness (especially when standing up)\n\nFlushing or warmth in the face\n\nLow blood pressure\n\nNausea\n\nRare but Serious Side Effects:\n\nFainting\n\nIrregular heartbeat\n\nSevere hypotension\n\nAllergic reactions (rash, itching, swelling, especially of the face/tongue/throat)\n\nNote: If you experience severe or persistent side effects, seek medical attention promptly.\n\nPrecautions:\n\nDo not use CARDULES ISMN 20 with phosphodiesterase inhibitors (e.g., sildenafil) as it may cause dangerously low blood pressure.\n\nInform your doctor if you have a history of heart failure, hypotension, anemia, or liver disease.\n\nAvoid alcohol while taking this medicine as it may enhance the blood pressure-lowering effects.\n\nNot recommended for children or pregnant women unless advised by a healthcare professional.\n\nCARDULES ISMN 20 is a clinically proven and effective option for the long-term management of angina pectoris. Regular and proper use can significantly reduce chest pain episodes and improve your heart health and quality of life.", "price": 26.0, "discountamount": 8.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "heart health", "heart muscle", "reduced risk", "medicine belongs", "longterm management", "effective option", "clinically proven", "pregnant women", "phosphodiesterase inhibitors", "experience severe", "facetonguethroat note", "nitratefree interval", "healthcare provider", "stop suddenly", "therapeutic effect", "empty stomach", "afternoon swallow", "daily preferably", "maintenance therapy", "cardules ismn 20", "active ingredient", "physical activity", "exercise tolerance", "admissions due", "hospitalization longterm", "heart making", "heartrelated complications", "preventing episodes", "critical role", "natural compound", "stable angina", "angina promotes", "blood vessels", "side effects", "work isosorbide mononitrate", "improve oxygen supply", "time side effects", "blood pressurelowering effects", "angina pectoris regular", "chronic angina directions", "prolonged action making", "longacting nitrate compound", "improves blood flow", "lowers oxygen demand", "relaxes smooth muscles", "releasing nitric oxide", "coronary artery disease" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2103, "imageuri": "https://productimages.withfloats.com/actual/681b27dac729bd6f360384db.png", "tileimageuri": "https://productimages.withfloats.com/tile/681b27dac729bd6f360384db.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-07T09:28:56.401Z", "updatedon": "2025-05-07T09:28:56.401Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/cardules-ismn-20/2103", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Isosorbide Mononitrate 20 mg", "category": "CARDIOLOGYRANGE", "tags": [ "Isosorbide Mononitrate 20 mg Uses in Hindi", "Isosorbide mononitrate 20 mg dose", "Isosorbide mononitrate 10mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68134d097702eb2332e5ccb0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLICLAGLAZE 40", "description": "GLICLAGLAZE 40 is an oral antidiabetic medication containing Gliclazide 40 mg, formulated to effectively manage Type 2 Diabetes Mellitus. It belongs to the class of drugs known as sulfonylureas, which are specifically designed to control blood glucose levels in adults who cannot manage diabetes through diet and exercise alone. By promoting insulin secretion and improving glycemic control, GLICLAGLAZE 40 helps prevent long-term complications associated with uncontrolled diabetes, such as nerve damage, kidney issues, and cardiovascular diseases.\n\nKey Ingredient\nGliclazide (40 mg):\nGliclazide is a second-generation sulfonylurea, known for its dual effect: stimulating insulin release from the pancreas and offering antioxidant properties. It not only lowers blood sugar but also provides vascular protection, making it suitable for patients at risk of cardiovascular events.\n\nKey Benefits\nEffectively reduces high blood sugar levels in Type 2 diabetes\n\nStimulates natural insulin secretion from pancreatic beta cells\n\nProvides cardiovascular protection by improving endothelial function\n\nMinimizes the risk of microvascular complications like retinopathy and nephropathy\n\nSuitable for long-term glycemic control when lifestyle measures are insufficient\n\nHelps maintain a stable glucose profile throughout the day\n\nHow Does It Work?\nGLICLAGLAZE 40 works by targeting the pancreas to enhance the secretion of insulin, which is essential for lowering blood glucose levels. Gliclazide binds to specific receptors on pancreatic beta cells, triggering the release of insulin in a glucose-dependent manner. This ensures that the medication works primarily when glucose levels are elevated, thus reducing the risk of hypoglycemia compared to older sulfonylureas. Additionally, its antioxidant properties contribute to improved vascular health, protecting blood vessels from oxidative damage often seen in diabetic patients.\n\nDirections for Use\nTake GLICLAGLAZE 40 exactly as prescribed by your healthcare provider\n\nUsually taken once or twice daily, preferably before meals\n\nSwallow the tablet whole with water — do not crush or chew\n\nMaintain a regular schedule for meals and medication to avoid hypoglycemia\n\nMonitor blood glucose levels regularly to track progress\n\nAlways combine with a balanced diet and exercise plan for optimal results\n\nSide Effects\nThough generally well-tolerated, GLICLAGLAZE 40 may cause some side effects:\n\nCommon Side Effects:\n\nHypoglycemia (low blood sugar)\n\nHeadache\n\nDizziness or light-headedness\n\nNausea or stomach discomfort\n\nWeight gain (in some patients)\n\nRare but Serious Side Effects:\n\nLiver enzyme abnormalities\n\nSkin rash or allergic reaction\n\nBlood disorders like anemia or thrombocytopenia\n\nVisual disturbances (usually temporary)\n\nSeek immediate medical attention if symptoms of severe hypoglycemia, such as confusion, fainting, or seizures, occur.", "price": 120.0, "discountamount": 34.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "gliclaglaze 40", "exercise plan", "balanced diet", "meals swallow", "nephropathy suitable", "gliclaglaze 40gliclaglaze 40", "seizures occur", "confusion fainting", "severe hypoglycemia", "medical attention", "temporary seek", "patients rare", "lightheadedness nausea", "track progress", "regular schedule", "daily preferably", "healthcare provider", "oxidative damage", "hypoglycemia compared", "glucosedependent manner", "specific receptors", "lifestyle measures", "microvascular complications", "secondgeneration sulfonylurea", "uncontrolled diabetes", "manage diabetes", "specifically designed", "chew maintain", "glucose levels", "cardiovascular protection", "promoting insulin secretion", "diabetic patients directions", "older sulfonylureas additionally", "medication works primarily", "oral antidiabetic medication", "stable glucose profile", "insufficient helps maintain", "vascular protection making", "thrombocytopenia visual disturbances", "antioxidant properties contribute", "longterm glycemic control", "pancreatic beta cells", "lowers blood sugar", "offering antioxidant properties" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2099, "imageuri": "https://productimages.withfloats.com/actual/68134d0b4b698d44a8c316f4.png", "tileimageuri": "https://productimages.withfloats.com/tile/68134d0b4b698d44a8c316f4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-01T10:29:29.141Z", "updatedon": "2025-05-01T10:29:29.141Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/gliclaglaze-40/2099", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Gliclazide 40 mg", "category": "DIABETIC RANGE", "tags": [ "Gliclazide 40 mg uses in Hindi", "Gliclazide 40mg brands", "Gliclazide 40 mg price", "Gliclazide 40mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666053368e599e12c0ea9a06", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PAFAGOLD 5 ", "description": "PAFAGOLD 5 \nDapagliflozin (5mg)\nIntroduction to PAFAGOLD 5\nPAFAGOLD 5 contains Dapagliflozin 5mg, a medication used primarily for the management of type 2 diabetes mellitus. Dapagliflozin belongs to a class of drugs known as SGLT2 (sodium-glucose co-transporter-2) inhibitors. It helps improve blood sugar control by preventing the kidneys from reabsorbing glucose back into the blood, allowing glucose to be excreted in the urine. This medication is typically used in combination with diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nWhat is Dapagliflozin?\nOverview of Dapagliflozin\nDapagliflozin is an SGLT2 inhibitor that works by blocking the reabsorption of glucose in the kidneys. This leads to the excretion of excess glucose through urine, thereby lowering blood sugar levels. Dapagliflozin also offers additional benefits such as weight loss and cardiovascular protection.\n\nMechanism of Action\nSGLT2 Inhibition: Dapagliflozin inhibits the SGLT2 protein in the kidneys, responsible for reabsorbing glucose back into the bloodstream. By blocking this protein, Dapagliflozin ensures that excess glucose is excreted in the urine.\nBlood Sugar Reduction: This mechanism helps lower blood sugar levels, particularly fasting blood glucose levels, contributing to overall glycemic control.\nBenefits of PAFAGOLD 5\nEffective Blood Sugar Management\nFasting Glucose Control: PAFAGOLD 5 helps lower fasting blood glucose levels by promoting the excretion of glucose through urine.\nComprehensive Glycemic Control: By targeting glucose reabsorption in the kidneys, Dapagliflozin provides a unique mechanism of action that complements other diabetes medications, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: PAFAGOLD 5 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, PAFAGOLD 5 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Dapagliflozin has been associated with weight loss due to the excretion of glucose and calories in the urine.\nCardiovascular Protection: SGLT2 inhibitors like Dapagliflozin have been shown to provide cardiovascular benefits, reducing the risk of heart failure and other cardiovascular events in diabetic patients.\nHow to Use PAFAGOLD 5\nDosage and Administration\nRecommended Dosage: The typical dosage of PAFAGOLD 5 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food. Swallow the tablet whole with a full glass of water. Consistency is key, so take the medication at the same time each day.\nGuidelines for Optimal Use\nConsistent Use: For best results, take PAFAGOLD 5 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/pafagold-5-134125", "price": 120.0, "discountamount": 36.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "diet", "food", "drugs", "urine", "class", "EMAIL", "Order", "water", "adults", "Action", "kidneys", "Support", "calories", "PAFAGOLD", "readings", "Overview", "excretion", "same time", "Guidelines", "one tablet", "full glass", "neuropathy", "Consistency", "bloodstream", "Adjustments", "weight loss", "information", "retinopathy", "combination", "Optimal Use", "Introduction", "sterisonline", "best results", "sterispharma", "Reduced Risk", "heart failure", "SGLT2 protein", "CALL/WHATSAPP", "Administration", "sodium-glucose", "typical dosage", "treatment plan", "Consistent Use", "excess glucose", "SGLT2 inhibitor", "Exercise Adjunct", "SGLT2 Inhibition", "unique mechanism", "Dapagliflozin 5mg", "Weight Management", "diabetic patients", "excellent adjunct", "Recommended Dosage", "individual response", "healthcare provider", "blood sugar control", "Diabetes Management", "additional benefits", "glucose reabsorption", "blood glucose levels", "Blood Sugar Reduction", "cardiovascular disease", "cardiovascular benefits", "Fasting Glucose Control", "lifestyle modifications", "long-term complications", "type 2 diabetes mellitus", "overall glycemic control", "transporter-2) inhibitors", "cardiovascular protection", "stable blood sugar levels", "Additional Health Benefits", "other diabetes medications", "other cardiovascular events", "Comprehensive Glycemic Control", "Effective Blood Sugar Management", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1388, "imageuri": "https://productimages.withfloats.com/actual/666053389917812fea5771aa.png", "tileimageuri": "https://productimages.withfloats.com/tile/666053389917812fea5771aa.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T11:59:50.713Z", "updatedon": "2024-06-29T11:06:57.321Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/pafagold-5-/1388", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PAFAGOLD 5 ", "category": "DIABETIC RANGE", "tags": [ "PAFAGOLD 5", "Dapagliflozin (5mg)", "Dapagliflozin 5 mg uses", "Dapagliflozin 5 mg price", "Dapagliflozin 5 mg dosage", "Dapagliflozin 5 mg substitute" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66605238a743fd235821fe26", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PAFAGOLD 10 ", "description": "PAFAGOLD 10 \nDapagliflozin (10mg)\nIntroduction to PAFAGOLD 10\nPAFAGOLD 10 contains Dapagliflozin 10mg, a medication primarily used for the management of type 2 diabetes mellitus. Dapagliflozin belongs to a class of drugs known as SGLT2 (sodium-glucose co-transporter-2) inhibitors. It helps improve blood sugar control by preventing the kidneys from reabsorbing glucose back into the blood, which allows glucose to be excreted in the urine. This medication is typically used in combination with diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nWhat is Dapagliflozin?\nOverview of Dapagliflozin\nDapagliflozin is an SGLT2 inhibitor that works by blocking the reabsorption of glucose in the kidneys. This leads to the excretion of excess glucose through urine, thereby lowering blood sugar levels. Dapagliflozin also offers additional benefits such as weight loss and cardiovascular protection.\n\nMechanism of Action\nSGLT2 Inhibition: Dapagliflozin inhibits the SGLT2 protein in the kidneys, which is responsible for reabsorbing glucose back into the bloodstream. By blocking this protein, Dapagliflozin ensures that excess glucose is excreted in the urine.\nBlood Sugar Reduction: This mechanism helps lower blood sugar levels, particularly fasting blood glucose levels, contributing to overall glycemic control.\nBenefits of PAFAGOLD 10\nEffective Blood Sugar Management\nFasting Glucose Control: PAFAGOLD 10 helps lower fasting blood glucose levels by promoting the excretion of glucose through urine.\nComprehensive Glycemic Control: By targeting glucose reabsorption in the kidneys, Dapagliflozin provides a unique mechanism of action that complements other diabetes medications, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: PAFAGOLD 10 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, PAFAGOLD 10 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Dapagliflozin has been associated with weight loss due to the excretion of glucose and calories in the urine.\nCardiovascular Protection: SGLT2 inhibitors like Dapagliflozin have been shown to provide cardiovascular benefits, reducing the risk of heart failure and other cardiovascular events in diabetic patients.\nHow to Use PAFAGOLD 10\nDosage and Administration\nRecommended Dosage: The typical dosage of PAFAGOLD 10 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food. Swallow the tablet whole with a full glass of water. Consistency is key, so take the medication at the same time each day.\nGuidelines for Optimal Use\nConsistent Use: For best results, take PAFAGOLD 10 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/pafagold-10-134126", "price": 135.0, "discountamount": 40.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "diet", "food", "drugs", "urine", "class", "EMAIL", "Order", "water", "adults", "Action", "kidneys", "Support", "calories", "PAFAGOLD", "readings", "Overview", "excretion", "same time", "Guidelines", "one tablet", "full glass", "neuropathy", "Consistency", "bloodstream", "Adjustments", "weight loss", "information", "retinopathy", "combination", "Optimal Use", "Introduction", "sterisonline", "best results", "sterispharma", "Reduced Risk", "heart failure", "SGLT2 protein", "CALL/WHATSAPP", "Administration", "sodium-glucose", "typical dosage", "treatment plan", "Consistent Use", "excess glucose", "SGLT2 inhibitor", "Exercise Adjunct", "SGLT2 Inhibition", "unique mechanism", "Weight Management", "diabetic patients", "excellent adjunct", "Dapagliflozin 10mg", "Recommended Dosage", "individual response", "healthcare provider", "blood sugar control", "Diabetes Management", "additional benefits", "glucose reabsorption", "blood glucose levels", "Blood Sugar Reduction", "cardiovascular disease", "cardiovascular benefits", "Fasting Glucose Control", "lifestyle modifications", "long-term complications", "type 2 diabetes mellitus", "overall glycemic control", "transporter-2) inhibitors", "cardiovascular protection", "stable blood sugar levels", "Additional Health Benefits", "other diabetes medications", "other cardiovascular events", "Comprehensive Glycemic Control", "Effective Blood Sugar Management", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1386, "imageuri": "https://productimages.withfloats.com/actual/6660523bc06ee12d88ce1635.png", "tileimageuri": "https://productimages.withfloats.com/tile/6660523bc06ee12d88ce1635.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T11:55:36.543Z", "updatedon": "2024-06-29T11:14:01.571Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//pafagold-10-/1386", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PAFAGOLD 10 ", "category": "DIABETIC RANGE", "tags": [ "PAFAGOLD 10", "Dapagliflozin (10mg)", "Dapagliflozin 10mg uses", "Dapagliflozin 10mg side effects", "Dapagliflozin 10 mg price", "Dapagliflozin 10 mg dosage" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68b6d6c76f14ecfa6add5d56", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SACUSMART 200", "description": "Description: \nSACUSMART 200 is a combination medicine containing Sacubitril (97 mg) and Valsartan (103 mg), specifically designed to manage chronic heart failure with reduced ejection fraction (HFrEF). This dual-acting therapy is classified as an angiotensin receptor neprilysin inhibitor (ARNI) and is widely prescribed to reduce the risk of cardiovascular death and hospitalization in patients with heart failure.\n\nHeart failure is a progressive condition where the heart cannot pump blood efficiently to meet the body’s needs. SACUSMART 200 improves the efficiency of the heart by relaxing blood vessels, reducing fluid retention, and lowering strain on the heart, helping patients live a better and longer life.\n\n \nWhat is SACUSMART 200?\n \n\nSACUSMART 200 is a highly effective heart failure medication that combines two active components:\n\nSacubitril (97 mg) – a neprilysin inhibitor that increases levels of natriuretic peptides, leading to vasodilation, sodium excretion, and reduced stress on the heart.\n\nValsartan (103 mg) – an angiotensin II receptor blocker (ARB) that relaxes blood vessels, lowers blood pressure, and prevents harmful effects of angiotensin II.\n\nTogether, these mechanisms make SACUSMART 200 a superior alternative to traditional ACE inhibitors or ARBs alone in treating chronic heart failure.\n\n \nUses of SACUSMART 200\n \n\nSACUSMART 200 is prescribed for:\n\nChronic heart failure with reduced ejection fraction (HFrEF)\n\nReducing risk of hospitalization due to worsening heart failure\n\nImproving survival rates in patients with heart failure\n\nEnhancing exercise tolerance and quality of life in long-term heart failure management\n\n \nBenefits of SACUSMART 200\n \n\nDual action with neprilysin inhibition + ARB effect for comprehensive heart protection\n\nProven to reduce mortality and hospitalization risk in heart failure patients\n\nImproves symptoms such as breathlessness, fatigue, and swelling\n\nHelps patients regain better physical stamina and daily activity levels\n\nLong-term use significantly contributes to improved quality of life\n\n \nPossible Side Effects of SACUSMART 200\n \n\nWhile SACUSMART 200 is effective and generally well tolerated, some patients may experience:\n\nLow blood pressure (hypotension)\n\nIncreased blood potassium levels (hyperkalemia)\n\nDizziness or light-headedness\n\nKidney function changes\n\nCough\n\nRarely, serious allergic reactions or angioedema (swelling of face, lips, or throat)\n\nImmediate medical attention is required if severe swelling, difficulty breathing, or fainting occurs.\n\n \nPrecautions Before Using SACUSMART 200\n \n\nDo not use if you are allergic to sacubitril, valsartan, or other ARBs\n\nAvoid if you have taken an ACE inhibitor within the last 36 hours due to the risk of angioedema\n\nNot recommended for patients with a history of hereditary angioedema\n\nCaution in patients with severe kidney or liver disease\n\nPregnant and breastfeeding women should avoid this medicine due to harmful effects on the baby\n\nAlways monitor blood pressure, kidney function, and potassium levels while on this treatment\n\n \nDrug Interactions\n \n\nSACUSMART 200 may interact with:\n\nACE inhibitors – should not be combined, risk of angioedema\n\nPotassium supplements or potassium-sparing diuretics – risk of high potassium\n\nNSAIDs (e.g., ibuprofen, naproxen) – may reduce kidney function\n\nLithium – risk of lithium toxicity\n\nDiuretics – may increase the risk of low blood pressure\n\nAlways inform your doctor about all medicines, supplements, or herbal products you are taking before starting SACUSMART 200.\n\n \nConclusion\n \n\nSACUSMART 200 (Sacubitril 97 mg & Valsartan 103 mg) is a breakthrough treatment in managing chronic heart failure with reduced ejection fraction (HFrEF). By combining neprilysin inhibition and angiotensin receptor blockade, it not only reduces symptoms but also significantly lowers the risk of hospitalization and death, improving both longevity and quality of life.\n\nFor patients living with heart failure, SACUSMART 200 offers a scientifically proven and clinically superior solution to regain control over their health and live a more fulfilling life.", "price": 750.0, "discountamount": 225.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2170, "imageuri": "https://productimages.withfloats.com/actual/68b6d6c9c4087f14f55d7d23.png", "tileimageuri": "https://productimages.withfloats.com/tile/68b6d6c9c4087f14f55d7d23.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-02T11:36:39.17Z", "updatedon": "2025-09-02T11:36:39.17Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sacusmart-200/2170", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Sacubitril and Valsartan Tablets (97 mg + 103 mg)", "category": "CARDIOLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6891f29bfb7044dfb2d43adf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MAGRAL 160", "description": "MAGRAL 160 is a pharmaceutical medication containing megestrol acetate 160 mg, a synthetic progestin known for its potent antineoplastic and appetite-stimulating properties. This drug is primarily prescribed to manage significant health challenges such as unexplained weight loss, anorexia, and cachexia, especially in patients suffering from chronic conditions like cancer or AIDS. Additionally, megestrol acetate functions as a hormone therapy agent employed in the treatment of certain hormone-sensitive malignancies. Its dual action both supports tumor management and improves patients' nutritional status by stimulating appetite and promoting weight gain, thereby enhancing overall quality of life. The drug is regarded as a crucial option in oncology and palliative care for managing complex conditions related to hormone-dependent cancers and severe wasting syndromes.\n\nWhat is MAGRAL 160?\nMAGRAL 160 is an oral medication formulated with megestrol acetate 160 mg, a synthetic progestin hormone derivative. It works primarily by modulating hormone receptors and altering hormone levels that influence the growth of hormone-responsive tumors such as breast and endometrial cancers. Apart from its antineoplastic action, it stimulates appetite by acting on the hypothalamic centers responsible for hunger, helping patients suffering from severe weight loss regain a healthy appetite and weight.\n\nUses of MAGRAL 160\n\nTo treat hormone-dependent cancers, specifically advanced breast cancer and endometrial cancer.\n\nTo stimulate appetite and promote weight gain in patients experiencing anorexia, cachexia, or unexplained severe weight loss related to chronic illnesses like cancer or AIDS.\n\nTo manage wasting syndromes that lead to malnutrition and significant weight loss.\n\nTo serve as an antineoplastic agent in hormone-sensitive malignancies.\n\nIn short, MAGRAL 160 is primarily used to treat anorexia and cachexia or serious unexplained weight loss and is also used as an antineoplastic agent to treat certain types of malignancy.\n\nSide Effects of MAGRAL 160\n\nWeight gain (often desirable but can be excessive)\n\nFluid retention and edema (swelling)\n\nNausea and vomiting\n\nDiarrhea or constipation\n\nVaginal bleeding or spotting in women\n\nFatigue, weakness, and insomnia\n\nHeadache and dizziness\n\nIncreased risk of blood clots (deep vein thrombosis or pulmonary embolism)\n\nHormonal imbalances, such as decreased sex hormone levels, which can lead to sexual dysfunction or bone density loss\n\nAllergic reactions including rash or itching\n\nPatients should report severe or unusual symptoms, especially signs of blood clots such as limb swelling, chest pain, or sudden shortness of breath, immediately to their healthcare provider.\n\nPrecautions before Using MAGRAL 160\n\nInform your doctor if you are pregnant, breastfeeding, or planning to conceive as MAGRAL 160 is contraindicated in pregnancy.\n\nDisclose any history of blood clots, cardiovascular diseases, liver or kidney impairment.\n\nPatients with diabetes should monitor blood sugar closely as megestrol acetate may cause hyperglycemia.\n\nAvoid sudden discontinuation without medical advice to prevent potential hormonal withdrawal effects.\n\nRegular monitoring is required, including hormone levels and blood tests, to assess efficacy and safety during treatment.\n\nUse cautiously in patients at risk for deep vein thrombosis or pulmonary embolism due to increased clotting risks.\n\nDrug Interactions: What Drugs Interact with MAGRAL 160?\n\nCYP3A4 enzyme inducers (e.g., rifampin, phenytoin) may reduce the effectiveness of megestrol acetate by increasing its metabolism.\n\nConcurrent use with blood thinners (anticoagulants) requires careful monitoring as MAGRAL 160 might influence clotting parameters.\n\nCombining with drugs that affect hormonal pathways, such as other hormonal therapies or corticosteroids, may alter treatment outcomes.\n\nInteractions with diabetes medications might necessitate dose adjustment due to potential effects on blood sugar control.\n\nCareful medical supervision is necessary when used with immunosuppressants or other chemotherapy agents to avoid additive side effects or altered drug levels.\n\nConclusion\nMAGRAL 160, containing megestrol acetate 160 mg, is a clinically validated medication widely used to manage complex conditions such as hormone-dependent cancers as well as severe weight loss due to anorexia and cachexia. Its unique ability to act both as an antineoplastic agent and an appetite stimulant makes it invaluable in improving patient outcomes, nutritional status, and overall quality of life. Patients prescribed MAGRAL 160 should adhere strictly to their healthcare provider’s instructions and report any adverse effects promptly. This medication should always be used under medical supervision to ensure optimal benefits and minimize risks.", "price": 810.0, "discountamount": 243.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2156, "imageuri": "https://productimages.withfloats.com/actual/6891f2a0115b51057b971998.png", "tileimageuri": "https://productimages.withfloats.com/tile/6891f2a0115b51057b971998.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-05T12:01:31.195Z", "updatedon": "2025-08-05T12:01:31.195Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/magral-160/2156", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "megestrol acetate 160 mg", "category": "Gynaecology", "tags": [ "megestrol acetate 160 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6890aa548a215c65672372e1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "EMPATECH LINA 25/5", "description": "EMPATECH LINA 25/5 is a pharmaceutical tablet containing a combination of two active ingredients: Empagliflozin 25MG and Linagliptin 5MG. This medication is designed to help manage blood sugar levels in adults with type 2 diabetes mellitus. The combination works through complementary mechanisms to improve glycemic control more effectively than either drug alone. Empagliflozin is a sodium-glucose cotransporter-2 (SGLT2) inhibitor that promotes the excretion of excess glucose through urine, while Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances insulin secretion and suppresses glucagon release, particularly after meals. EMPATECH LINA 25/5 is generally prescribed alongside a balanced diet and regular exercise to optimize blood sugar management and reduce the risk of diabetes-related complications such as kidney damage, neuropathy, and cardiovascular issues.\n\nWhat is EMPATECH LINA 25/5?\n\nEMPATECH LINA 25/5 is a prescription medication combining Empagliflozin (25MG) and Linagliptin (5MG) tablets used to manage type 2 diabetes. It helps control elevated blood sugar levels by using dual actions — the removal of glucose via kidneys and improving pancreatic hormone responses. This combination aims to achieve better and sustained glycemic control, often necessary for patients who have inadequate blood sugar control with other treatments.\n\nUses of EMPATECH LINA 25/5\n\nTo improve blood sugar control in adults with type 2 diabetes, particularly when monotherapy is insufficient.\n\nOften used as a second-line therapy after metformin or when metformin is not tolerated.\n\nTo reduce HbA1c (hemoglobin A1c), an important measure of long-term glucose control.\n\nMay help reduce weight and blood pressure as empagliflozin aids in glucose excretion.\n\nSupports comprehensive diabetes management along with diet and exercise.\n\nPrevents or reduces the risk of diabetes-associated complications such as kidney disease, cardiovascular events, and nerve damage.\n\nSide Effects of EMPATECH LINA 25/5\n\nCommon side effects may include urinary tract infections and genital infections due to increased glucose in urine.\n\nIncreased urination and dehydration.\n\nDizziness or lightheadedness, especially when standing up quickly.\n\nHypoglycemia (low blood sugar), though rare with this combination.\n\nGastrointestinal symptoms such as nausea or diarrhea.\n\nPotential increased risk of ketoacidosis (a serious condition related to high blood acids) in rare cases.\n\nAllergic reactions, although uncommon, may occur and require prompt medical attention.\n\nPrecautions Before Using EMPATECH LINA 25/5\n\nInform your healthcare provider if you have kidney disease, liver problems, or a history of urinary tract infections.\n\nNot recommended for type 1 diabetes or diabetic ketoacidosis treatment.\n\nUse with caution if you are pregnant, planning to become pregnant, or breastfeeding.\n\nStay hydrated while on this medication to reduce the risk of dehydration and dizziness.\n\nInform your doctor about any history of pancreatitis or pancreas disorders.\n\nRegular monitoring of kidney function and blood sugar levels is advised during treatment.\n\nAvoid drinking excessive alcohol as it may increase side effects or risk of ketoacidosis.\n\nDrug Interactions: What Drugs Interact with EMPATECH LINA 25/5?\n\nOther antidiabetic medications, such as insulin or sulfonylureas, may increase the risk of hypoglycemia.\n\nDiuretics, blood pressure medications, and lithium may interact and increase side effects.\n\nDrugs that impair kidney function can affect empagliflozin’s efficacy and safety.\n\nCertain enzyme-inducing drugs may reduce linagliptin levels, lowering its effectiveness.\n\nConsult your healthcare provider for a full list of possible interactions and before starting any new medication, including over-the-counter drugs or supplements.\n\nConclusion\n\nEMPATECH LINA 25/5, containing Empagliflozin 25MG and Linagliptin 5MG, is an effective combination medication to treat high blood sugar levels caused by type 2 diabetes. Its dual-action approach targets different physiological mechanisms to improve blood glucose control, helping reduce the risks and complications associated with diabetes. While it is generally well-tolerated, awareness of possible side effects and drug interactions is important. Always use under medical supervision, alongside lifestyle modifications such as diet and exercise, for optimal diabetes management.", "price": 345.0, "discountamount": 104.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2154, "imageuri": "https://productimages.withfloats.com/actual/6890aa58dd0bc098c3220f4c.png", "tileimageuri": "https://productimages.withfloats.com/tile/6890aa58dd0bc098c3220f4c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-04T12:40:52.619Z", "updatedon": "2025-08-04T12:40:52.619Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empatech-lina-25-5/2154", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Empagliflozin and Linagliptin Tablets", "category": "DIABETIC RANGE", "tags": [ "Empagliflozin and Linagliptin Tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68592ed41870d4affba8adc1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "STYLECYSTIN LACTO", "description": "STYLECYSTIN LACTO combines two powerful, scientifically backed ingredients—N-Acetyl Cysteine (NAC) and Lactoferrin—to support respiratory health, immune function, and antioxidant protection. This dual-action tablet is designed for optimal bioavailability, delivering targeted support for individuals seeking relief from mucus congestion, enhanced immune defenses, and overall cellular wellness.\n\nWhat Is STYLECYSTIN LACTO?\nSTYLECYSTIN LACTO is a synergistic supplement featuring:\n\nN-Acetyl Cysteine (NAC) (600 mg): A precursor to the antioxidant glutathione, NAC helps thin and loosen mucus in the airways while neutralizing free radicals.\n\nLactoferrin (100 mg): A naturally occurring glycoprotein with antimicrobial and immunomodulatory properties that supports iron homeostasis and strengthens innate immunity.\n\nTogether, these n-acetyl cysteine and lactoferrin tablets offer comprehensive respiratory and immune support in one convenient dose.\n\nUses of N-Acetyl Cysteine and Lactoferrin Tablets\nMucolytic Therapy\n\nNAC breaks down disulfide bonds in mucus, promoting easier expectoration in conditions like chronic bronchitis, COPD, and sinusitis.\n\nAntioxidant Support\n\nNAC boosts glutathione synthesis, scavenging free radicals and protecting cells from oxidative stress.\n\nImmune Enhancement\n\nLactoferrin modulates immune cell function, inhibits pathogen growth by sequestering iron, and supports a balanced inflammatory response.\n\nUpper Respiratory Health\n\nCombined action helps reduce the frequency and severity of viral and bacterial respiratory tract infections.\n\nGut–Immune Axis Support\n\nLactoferrin promotes a healthy gut microbiome, supporting digestive wellness and systemic immunity.\n\nSide Effects of STYLECYSTIN LACTO\nWhile n-acetyl cysteine and lactoferrin tablets are generally well tolerated, some individuals may experience:\n\nGastrointestinal Discomfort: Nausea, bloating, or loose stools (usually mild and transient)\n\nAllergic Reactions: Rare skin rash, itching, or hives—more likely in those with milk protein sensitivities (due to lactoferrin)\n\nHeadache or Dizziness: Occasional, typically improves with continued use\n\nUnpleasant Odor: NAC may produce a mild sulfur-like taste or smell\n\nIf side effects persist or worsen, discontinue use and consult your healthcare provider.\n\nPrecautions Before Using STYLECYSTIN LACTO\nBefore starting STYLECYSTIN LACTO, consider the following:\n\nAllergy Alert: Do not use if you have a known allergy to N-Acetyl Cysteine, lactoferrin, or milk-derived proteins.\n\nAsthma & Bronchospasm: Use cautiously in patients with asthma, as NAC’s mucolytic effect may trigger bronchospasm in sensitive individuals.\n\nPeptic Ulcer Disease: NAC can irritate the gastrointestinal mucosa; avoid or monitor closely if you have active ulcers.\n\nPregnancy & Breastfeeding: Safety in pregnant or lactating women has not been fully established—consult your doctor.\n\nDosage Compliance: Adhere strictly to the recommended dose; do not exceed without medical supervision.\n\nDrug Interactions: What Drugs Interact with STYLECYSTIN LACTO?\nNitroglycerin & Other Vasodilators\n\nCo-administration with NAC may increase the risk of hypotension or headaches.\n\nActivated Charcoal\n\nMay bind NAC in the gut, reducing its absorption and efficacy.\n\nAntibiotics (e.g., Tetracyclines, Quinolones)\n\nLactoferrin’s iron-sequestering action could reduce antibiotic bioavailability; take antibiotics at least 2 hours apart.\n\nAnticoagulants (Warfarin)\n\nNAC may potentiate anticoagulant effects; monitor INR levels closely.\n\nChemotherapeutic Agents\n\nHigh-dose antioxidants like NAC could, in theory, interfere with oxidative mechanisms of certain chemotherapies—use only under oncology guidance.\n\nAlways inform your healthcare provider about all prescription drugs, over-the-counter medications, and supplements you are taking to minimize the risk of adverse interactions.", "price": 380.0, "discountamount": 114.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "2 hours", "nacetyllcysteine lactoferrin", "efficacy antibiotics", "allergy alert", "adverse interactions", "oncology guidance", "oxidative mechanisms", "theory interfere", "gut reducing", "bind nac", "vasodilators coadministration", "drugs interact", "recommended dose", "fully establishedconsult", "lactating women", "monitor closely", "trigger bronchospasm", "worsen discontinue", "lactoferrin headache", "loose stools", "lactoferrin tablets", "protecting cells", "disulfide bonds", "convenient dose", "immune support", "immunomodulatory properties", "loosen mucus", "cellular wellness", "dualaction tablet", "antioxidant protection", "sequestering iron", "healthcare provider", "stylecystin lacto", "supports iron homeostasis", "anticoagulants warfarin nac", "stylecystin lacto nitroglycerin", "starting stylecystin lacto", "healthcare provider precautions", "mild sulfurlike taste", "unpleasant odor nac", "individuals seeking relief", "reduce antibiotic bioavailability", "headaches activated charcoal", "gastrointestinal mucosa avoid", "nacs mucolytic effect", "side effects persist", "chronic bronchitis copd", "strengthens innate immunity", "naturally occurring glycoprotein" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2136, "imageuri": "https://productimages.withfloats.com/actual/68592ed8063f465b69614423.png", "tileimageuri": "https://productimages.withfloats.com/tile/68592ed8063f465b69614423.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-06-23T10:39:16.489Z", "updatedon": "2025-06-23T12:32:24.459Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/stylecystin-lacto/2136", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "n-acetyl cysteine and lactoferrin tablets", "category": "NEPHROLOGYRANGE", "tags": [ "n-acetyl-l-cysteine and lactoferrin tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "683d992c87328f4e892f8716", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "EMPATECH 25", "description": "EMPATECH 25 is an advanced oral medication formulated with Empagliflozin 25 mg, a trusted and effective treatment for managing Type 2 Diabetes Mellitus (T2DM). It is part of a class of drugs known as SGLT2 inhibitors (sodium-glucose co-transporter 2 inhibitors), designed to help lower blood sugar levels in adults when used alongside proper diet and exercise. EMPATECH 25 not only improves glycemic control but also contributes to weight management and cardiovascular health in diabetic patients.\n\nKey Ingredients\nEmpagliflozin 25 mg: A selective SGLT2 inhibitor that helps remove excess glucose from the body through urine, lowering blood sugar levels in patients with type 2 diabetes.\n\nKey Benefits\nHelps significantly reduce elevated blood glucose (HbA1c) levels in Type 2 Diabetes\n\nSupports weight loss by reducing excess sugar stored in the body\n\nAids in lowering systolic blood pressure\n\nDemonstrated cardiovascular benefits, including reduced risk of heart failure hospitalization\n\nEnhances overall glycemic control without causing hypoglycemia when used alone\n\nConvenient once-daily oral dosing\n\nHow Does It Work?\nEmpagliflozin blocks the SGLT2 protein in the kidneys, which is responsible for reabsorbing glucose back into the bloodstream.\n\nBy inhibiting this protein, the medication increases glucose excretion through urine, thereby lowering blood sugar levels.\n\nIt works independently of insulin, making it a suitable option even when insulin resistance is present.\n\nAdditionally, this mechanism reduces blood pressure and body weight, offering multiple metabolic benefits beyond blood sugar control.\n\nDirections for Use\nTake one tablet of EMPATECH 25 orally once a day, preferably at the same time each day.\n\nIt can be taken with or without food.\n\nFollow the dosage as prescribed by your healthcare provider.\n\nDo not crush, chew, or break the tablet; swallow it whole with water.\n\nMaintain regular blood sugar monitoring and adhere to a balanced diet and exercise regimen.\n\nSide Effects\nIncreased urination\n\nGenital infections (e.g., yeast infections)\n\nUrinary tract infections (UTIs)\n\nThirst and mild dehydration\n\nLow blood pressure (especially in people on diuretics)\n\nDizziness or lightheadedness\n\nPossible increase in cholesterol levels\n\nIn rare cases, ketoacidosis (seek immediate medical attention if symptoms like nausea, vomiting, or abdominal pain occur)", "price": 225.0, "discountamount": 68.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "tablet swallow", "day preferably", "body aids", "nausea vomiting", "medical attention", "cholesterol levels", "diuretics dizziness", "crush chew", "healthcare provider", "food follow", "empatech 25 orally", "present additionally", "insulin resistance", "suitable option", "insulin making", "works independently", "sglt2 protein", "causing hypoglycemia", "reduced risk", "cardiovascular health", "weight management", "exercise empatech 25", "effective treatment", "empatech 25empatech 25", "balanced diet", "empagliflozin 25 mg", "glycemic control", "improves glycemic control", "work empagliflozin blocks", "selective sglt2 inhibitor", "alongside proper diet", "abdominal pain occur", "reabsorbing glucose back" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2130, "imageuri": "https://productimages.withfloats.com/actual/683d99313e1ed3094cddca21.png", "tileimageuri": "https://productimages.withfloats.com/tile/683d99313e1ed3094cddca21.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-06-02T12:29:32.123Z", "updatedon": "2025-06-02T12:31:28.199Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empatech-25/2130", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Empagliflozin 25 mg", "category": "DIABETIC RANGE", "tags": [ "empagliflozin 25 mg", "empagliflozin 25 mg tablet", "Empagliflozin 25 mg brands in India", "Empagliflozin 25 mg Price in India" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }